Delivery Order SPE2DP20D0002-SPE2DP20F6219
- Not listed
- The U.S. Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Teva Pharmaceuticals USA, Inc. for the delivery of Adenovirus Type 4 vaccines. The $135,747.00 contract has an August 25, 2020 completion date. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit manufacturer that has provided a range of pharmaceutical products, including vaccines, antiviral medications, and respiratory treatments, to federal customers such as the Department of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The $282,353.76 contract has an April 27, 2021 completion date and does not have a set-aside designation. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that has supplied various pharmaceutical products, including vaccines, antiviral medications, respiratory...
- This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The contract is a $271,494 firm-fixed price delivery order with a completion date of June 23, 2020. Teva Pharmaceuticals USA, Inc. is a for-profit, foreign-owned organization that has previously supplied pharmaceutical products including vaccines, antivirals, and respiratory treatments to government...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to supply Adenovirus Type 4 vaccine. The $282,353.76 contract has a completion date of January 26, 2021. Teva Pharmaceuticals is a foreign-owned, for-profit organization that provides a range of drug products to federal agencies, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs. The...
- This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc. for the supply of Adenovirus Type 4 vaccine. The award has a potential value of $135,747.00 and a completion date of June 23, 2020. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit pharmaceutical manufacturer that has provided a range of drug products, including vaccines, antiviral medications, respiratory treatments, and multiple...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $476,414.19 firm-fixed-price delivery order to provide Adenovirus Type 4 vaccine. The contract has a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and has been awarded numerous prime contracts by federal agencies such as the...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $158,804.73 contract, which has no set-aside designation, is for the supply of Adenovirus Type 4 A vaccine with a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. has been awarded multiple federal contracts and delivery orders from agencies like the Department of Veterans...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed-price delivery order worth $458,090.64 to Teva Pharmaceuticals USA, Inc., a foreign-owned for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This contract supports military immunization programs. Teva is an experienced federal contractor, having provided a variety of drug products, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs, to...
- This federal contract award, valued at $990,941.58, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is a delivery order for the supply of Adenovirus Type 4 vaccine, a critical medical product that supports military immunization programs. The contract is a firm-fixed-price arrangement with a period of performance through March 25, 2025. Teva Pharmaceuticals USA, Inc....
- Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit manufacturer, was awarded a $135,747 delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Adenovirus Type 4 vaccine. The order has a completion date of September 29, 2020 and was issued under a firm-fixed price contract. Teva is an experienced provider of pharmaceutical products, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs, to federal agencies...
- SPE2DP20D0002Indefinite Delivery Contract
- SPE2DP20D0002-SPE2DP20F6219Delivery Order
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, for the delivery of Adenovirus Type 4 vaccine. The contract is a firm-fixed price Delivery Order with a potential value of $135,747.00 and a completion date of July 28, 2020. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that manufactures a range of drug products, including vaccines, for U.S. government agencies such as the Department of Defense and Department of Veterans Affairs. This contract supports the military's immunization programs, and Teva has previously received similar delivery orders from DLA Troop Support Medical. The contract does not have a set-aside designation.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
ADENOVIRUS TYPE 4 A | SPE2DP18R01130009 | Defense Logistics Agency Troop Support Medical | Award Notice 1/1 | 2/3/20, 2:02 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $135.7k | 7/22/20 |